German study published in February 2021 showed that cannabis could be a promising treatment for reducing pain and muscle cramps in Parkinson’s patients.
Researchers at Germany’s University Medical Center Hamburg-Eppendorf Department of Neurology found that 61% of patients with Parkinson’s disease who used medical cannabis (CBD or THC) reported a beneficial clinical effect.
According to a study published in the Journal of Parkinson’s Disease the improvement of symptoms was reported by 54% of users applying oral CBD and 68% inhaling THC-containing cannabis. Compared to CBD intake, inhalation of THC was more frequently reported to reduce akinesia and stiffness (50.0% vs. 35.4%; p < 0.05). Interest in using MC was reported by 65% of non-users.
Bastiaan R. Bloem, MD, Ph.D., the director for the Radboudumc Center of Expertise for Parkinson & Movement Disorders and co-editor-in-chief of the Journal of Parkinson’s Disease, called the study results “interesting in that they confirm a widespread interest among (Parkinson’s) patients in the use of cannabis as a potential treatment.”
B.Bloem and Dr. Carsten Buhmann, a Department of Neurology professor and lead author of this study, said more research is needed for medical cannabis as a therapy for the disease. According to the Parkinson’s Foundation, more than 10 million people worldwide are diagnosed with the condition.
Original article with results of study you find here:
https://content.iospress.com/articles/journal-of-parkinsons-disease/jpd202260